TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
China Health Group ( (HK:0673) ) has issued an announcement.
China Health Group Limited has announced significant changes in its leadership structure, appointing Mr. Cao Xu as the new executive director and chairman of the board, effective October 31, 2025. Mr. Cao brings extensive experience in investments and the pharmaceutical industry, which is expected to enhance the company’s strategic direction and strengthen its market position. Additionally, Ms. Ying Rensi has been appointed as an executive director, further contributing to the company’s leadership team.
The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.
More about China Health Group
China Health Group Limited operates in the healthcare industry, focusing on investments and pharmaceutical services. The company is involved in various aspects of healthcare and pharmaceutical engineering, with a market presence in Hong Kong.
Average Trading Volume: 665,568
Technical Sentiment Signal: Buy
Current Market Cap: HK$669.6M
See more data about 0673 stock on TipRanks’ Stock Analysis page.